Franklin Biotechnology Discovery Fund Investor Sentiment

FRBRX Fund  USD 147.44  1.08  0.74%   
Slightly above 53% of Franklin Biotechnology's investor base is interested to short. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that many investors are impartial at this time. Franklin Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Franklin Biotechnology's earnings reports, geopolitical events, and overall market trends.
  
over three weeks ago at news.google.com         
Franklin Biotechnology Discovery Fund Q3 2024 Commentary - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Franklin Biotechnology Discovery Fund Q2 2024 Commentary - Seeking Alpha
Google News at Macroaxis
a day ago at gurufocus.com         
Incyte Corp to Present at 43rd Annual J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
3 days ago at finance.yahoo.com         
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca i...
Yahoo News
few days ago at businesswire.com         
Riassunto Gli ultimi dati su Tafasitamab di Incyte allASH 2024 dimostrano una sopravvivenza libera d...
businesswire News
few days ago at businesswire.com         
Resumen Los datos de ltima hora de Incyte sobre tafasitamab en ASH 2024 demuestran una mejora signif...
businesswire News
six days ago at zacks.com         
Biotech Stock Roundup BIOA Down on Study Update, QURE, CRDF Gain on Study Data More
zacks News
over a week ago at businesswire.com         
Incyte Late-Breaking Tafasitamab Data at ASH 2024 Demonstrate Significantly Improved Progression-Fre...
businesswire News
over a week ago at gurufocus.com         
Incyte Corp Announces Promising Phase 3 Trial Results for Tafasitamab in Follicular Lymphoma
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Incytes Late-stage NSCLC Study Meets Primary and Secondary Goals
Yahoo News
over a week ago at investing.com         
Achieve Life Sciences names new CFO
Investing News at Macroaxis
over a week ago at thefly.com         
Incyte announces results from Phase 3 trial evaluating retifanlimab in NSCLC INCY
news
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
six days ago at finance.yahoo.com         
Is Array Technologies the Best Alternative Fuel Stock to Buy According to Hedge Funds?
Yahoo News
over a week ago at finance.yahoo.com         
Why Array Technologies Is Among the Best Wind Power and Solar Stocks to Invest in Now
Yahoo News
over two weeks ago at seekingalpha.com         
ARRAY Technologies names Jennings as CFO
seekingalpha News
over two weeks ago at gurufocus.com         
Array Technologies Stock Surges Amid Mixed Financial Performance
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
ARRAY Technologies Appoints Two Industry Veterans to Lead EMEA
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Acquisition by Stacherski Kenneth R. of 30132 shares of Array Technologies subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Goldman Sachs Group Incs Strategic Acquisition of Shares in Array Technologies Inc
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Array Technologies Inc Q3 2024 Earnings Call Highlights Navigating Challenges with ...
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2024 Delivers exceptional g...
Yahoo News
over a month ago at finance.yahoo.com         
Array Misses Q3 Revenue Estimates, Stock Drops
Yahoo News
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
a day ago at zacks.com         
4 Big Drug Stocks That May Continue to Outperform in 2025
zacks News
3 days ago at thelincolnianonline.com         
Vertex, Inc. Shares Acquired by Lord Abbett CO. LLC
news
few days ago at thelincolnianonline.com         
Sunbelt Securities Inc. Sells 65 Shares of Vertex Pharmaceuticals Incorporated
news
few days ago at benzinga.com         
100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
benzinga news
few days ago at thelincolnianonline.com         
World Investment Advisors LLC Acquires Shares of 52,206 Vertex Pharmaceuticals Incorporated
news
few days ago at finnewsnetwork.com.au         
Google and the agentic era of AI
news
six days ago at techcrunch.com         
Gemini 2.0, Googles newest flagship AI, can generate text, images, and speech
news
six days ago at androidcentral.com         
Googles latest AI model, Gemini 2.0, is here to usher in the agentic era
news
over a week ago at gurufocus.com         
Jefferies Upgrades Vertex Pharmaceuticals to Buy Amid Strong RD Prospects
Gurufocus Stories at Macroaxis
over a week ago at cnbc.com         
Wall Street is turning bullish on this biotech. How to play it with options
cnbc News
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over a year ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Stock Holdings Trimmed by Swiss National Bank
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over a year ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over a year ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over a year ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over a year ago at Macroaxis         
Should you quit your Reata Pharmaceuticals (USA Stocks:RETA) holdings?
Macroaxis News
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Cut to Neutral at LADENBURG THALMSH SH
news
a day ago at finance.yahoo.com         
Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Yahoo News
3 days ago at investing.com         
Regenerons SWOT analysis eylea franchise faces challenges as stock navigates pipeline potential
Investing News at Macroaxis
few days ago at simplywall.st         
Is Regeneron Pharmaceuticals Using Too Much Debt?
Simply Wall St News at Macroaxis
few days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals, Inc. Stock Position Lowered by Sanctuary Advisors LLC
news
six days ago at investing.com         
Disc Medicines SWOT analysis stock potential amid mixed trial results
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising E...
Yahoo News
over a week ago at finance.yahoo.com         
Acquisition by Marion McCourt of 2332 shares of Regeneron Pharmaceuticals subject to Rule 16b-3
Yahoo News
over a week ago at businesswire.com         
Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising E...
businesswire News
over a week ago at thelincolnianonline.com         
Y Intercept Hong Kong Ltd Purchases Shares of 9,425 Regeneron Pharmaceuticals, Inc.
news
over a week ago at gurufocus.com         
Disposition of 492 shares by Joseph LaRosa of Regeneron Pharmaceuticals at 787.0 subject to Rule 16b...
Gurufocus Stories at Macroaxis
a day ago at finance.yahoo.com         
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
few days ago at seekingalpha.com         
PTC Therapeutics upgraded to Overweight at Morgan Stanley
seekingalpha News
over a week ago at investors.com         
UniQure Stock Nearly Doubles After Striking A Deal With The FDA For Huntingtons Drug
Investors Business Daily at Macroaxis
over a week ago at gurufocus.com         
Insider Sell Alert Christine Utter Sells 17,800 Shares of PTC Therapeutics Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Insider Sell Alert Jerome Zeldis Sells 24,000 Shares of PTC Therapeutics Inc
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
PTC Therapeutics Given New 32.00 Price Target at Citigroup
news
over two weeks ago at finance.yahoo.com         
PTCT Stock Soars on Licensing Deal With NVS for Huntingtons Therapy
Yahoo News
over two weeks ago at investing.com         
PTC Therapeutics stock target boosted, outperform on Novartis deal
Investing News at Macroaxis
over two weeks ago at investing.com         
Disposition of 83640 shares by Mark Boulding of PTC Therapeutics at 51.0 subject to Rule 16b-3
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
PTC Therapeutics Stock Soars on Novartis Licensing Agreement
Yahoo News
a day ago at finance.yahoo.com         
Trump says were going to knock out the middleman and eliminate pharmacy benefit managers that he cla...
Yahoo News
few days ago at finance.yahoo.com         
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of Firs...
Yahoo News
few days ago at finance.yahoo.com         
Sanofis combo vaccines gain FDA fast track designation
Yahoo News
few days ago at finance.yahoo.com         
Why Is Novavax Up 13.6 percent Since Last Earnings Report?
Yahoo News
six days ago at zacks.com         
FDA Grants Fast Track Tag to SNYs Two COVID Flu Vaccine Candidates
zacks News
over a week ago at finance.yahoo.com         
Novavax, Inc. is Attracting Investor Attention Here is What You Should Know
Yahoo News
over a week ago at aol.com         
Trumps first term brought world-changing vaccine. His second could bring retreat
news
over a week ago at gurufocus.com         
Novavax Shares Surge as Czech Facility Sold to Novo Nordisk
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
2 Beaten-Down Pandemic Stocks to Consider for Contrarian Investors
Yahoo News
over a week ago at thelincolnianonline.com         
Novavax, Inc. Shares Sold by Martingale Asset Management L P
news
over six months ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over six months ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over six months ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over six months ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over six months ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
a minute ago at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
2 days ago at investing.com         
Jazz Pharmaceuticals CEO to retire by end of 2025
Investing News at Macroaxis
few days ago at investing.com         
Werewolf Therapeutics SWOT analysis oncology stocks potential amid clinical trials
Investing News at Macroaxis
six days ago at thelincolnianonline.com         
Y Intercept Hong Kong Ltd Sells 11,622 Shares of Jazz Pharmaceuticals plc
news
over a week ago at investing.com         
Avadel Pharmaceuticals director Linda Palczuk buys 30,567 in shares
Investing News at Macroaxis
over a week ago at thelincolnianonline.com         
Quantinno Capital Management LP Acquires 42,924 Shares of Jazz Pharmaceuticals plc
news
over a week ago at finance.yahoo.com         
Jazz Up 3.4 percent Since Last Earnings Report Can It Continue?
Yahoo News
over a week ago at finance.yahoo.com         
Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network Clinical Practice Gui...
Yahoo News
over a week ago at investing.com         
Jazz Pharmaceuticals chief accounting officer sells 6,491 in shares
Investing News at Macroaxis
over two weeks ago at aol.com         
Lakers catch a break and hold on to defeat the Utah Jazz
news
few days ago at thelincolnianonline.com         
Public Employees Retirement System of Ohio Sells 1,861 Shares of Intra-Cellular Therapies, Inc.
news
six days ago at gurufocus.com         
Intra-Cellular Therapies Inc Presents Promising Data on CAPLYTA for Major Depressive Disorder
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Intra-cellular Therapies CEO sells 8.72 million in stock
Investing News at Macroaxis
over a week ago at simplywall.st         
Loss-Making Intra-Cellular Therapies, Inc. Expected To Breakeven In The Medium-Term
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Intra-Cellular Therapies Submits Supplemental New Drug Application to FDA for CAPLYTA for the Treatm...
Yahoo News
over two weeks ago at investing.com         
Intra-Cellular Therapies stock rated Outperform by Mizuho, with 13 percent stock rise post-earnings
Investing News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Disposition of 306 shares by Sharon Mates of Intracellular at 67.33 subject to Rule 16b-3
news
over a month ago at investing.com         
Disposition of 13371 shares by Halstead Michael of Intracellular at 88.17 subject to Rule 16b-3
Investing News at Macroaxis
over a month ago at gurufocus.com         
FMR LLC Reduces Stake in Intra-Cellular Therapies Inc
Gurufocus Stories at Macroaxis
over a month ago at simplywall.st         
Revenues Tell The Story For Intra-Cellular Therapies, Inc. As Its Stock Soars 26
Simply Wall St News at Macroaxis
a day ago at fool.com         
2 Growth Stocks That Could Rocket Higher in 2025 Are They Right for Your Portfolio?
fool News
few days ago at finance.yahoo.com         
Prediction This Stock Will Beat the Market in 2025
Yahoo News
over two weeks ago at finance.yahoo.com         
Iovance Biotherapeutics, Inc. is a favorite amongst institutional investors who own 63
Yahoo News
over two weeks ago at finance.yahoo.com         
Is Iovance Biotherapeutics Stock a Millionaire Maker?
Yahoo News
over three weeks ago at fool.com         
Got 1,500 Buy Iovance Biotherapeutics Now and Dont Look Back
fool News
over a month ago at fool.com         
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
fool News
over a month ago at gurufocus.com         
Perceptive Advisors LLCs Strategic Acquisition in Viridian Therapeutics Inc
Gurufocus Stories at Macroaxis
over a month ago at insidermonkey.com         
Iovance Biotherapeutics, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a month ago at gurufocus.com         
Iovance Biotherapeutics Inc Q3 2024 Earnings Call Highlights Surpassing Revenue ...
Gurufocus Stories at Macroaxis
over a month ago at seekingalpha.com         
Iovance Biotherapeutics GAAP EPS of -0.28 beats by 0.02, revenue of 58.6M beats by 4.78M
seekingalpha News
over a year ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
a day ago at finance.yahoo.com         
Ovation.io and Illumina Collaborate to Advance Genomic Data Research
Yahoo News
3 days ago at investing.com         
Illuminas SWOT analysis stock faces pricing headwinds amid market leadership
Investing News at Macroaxis
few days ago at thelincolnianonline.com         
Illumina, Inc. Stake Lowered by Public Employees Retirement System of Ohio
news
few days ago at simplywall.st         
What Does Illumina, Inc.s Share Price Indicate?
Simply Wall St News at Macroaxis
few days ago at businesswire.com         
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer President to Drive Commercial Grow...
businesswire News
six days ago at finance.yahoo.com         
TMO Institutional Insider Stock Sell-Offs Upset Market How to Play
Yahoo News
over a week ago at finance.yahoo.com         
The World Market for Blood Ketone Meters, Forecast to 2029 Discover Regional Business Trends for Hum...
Yahoo News
over a week ago at gurufocus.com         
Illumina Inc Achieves Breakthrough in Genomic Sequencing with DRAGEN Software
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Illumina Inc Stock Price Up 4.78 percent on Dec 9
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27 percent CAGR Report by SS Insider
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a day ago at seekingalpha.com         
Gilead gets FDA breakthrough therapy status for Trodelvy
seekingalpha News
3 days ago at investing.com         
Gilead Sciences SWOT analysis lenacapavir success fuels HIV stock growth
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Disposition of 157 shares by Sandra Patterson of Gilead Sciences subject to Rule 16b-3
Yahoo News
few days ago at zacks.com         
Gilead Sciences Stock Moves -0.57 percent What You Should Know
zacks News
few days ago at finance.yahoo.com         
Is Gilead Sciences Stock Undervalued Right Now?
Yahoo News
few days ago at raskmedia.com.au         
2 ETFs I think any ASX investor would love to own
news
six days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Stake Cut by Bard Financial Services Inc.
news
six days ago at finance.yahoo.com         
QURE Soars on FDA Alignment for Speedy Approval of Huntingtons Drug
Yahoo News
over a week ago at investing.com         
Ipsen SA shares target upgraded, rating held on growth outlook
Investing News at Macroaxis
over a week ago at seekingalpha.com         
BofA restarts coverage of 11 large-cap biopharmas
seekingalpha News
over six months ago at seekingalpha.com         
Ono Pharmaceutical completes tender offer for Deciphera
seekingalpha News
over six months ago at finance.yahoo.com         
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study o...
Yahoo News
over six months ago at news.google.com         
Charles Schwab Investment Management Inc. Has 8.31 Million Position in Deciphera Pharmaceuticals, In...
Google News at Macroaxis
over six months ago at news.google.com         
Decipheras Shares Surge 74.3 percent in a Month Heres Why - Zacks Investment Research
Google News at Macroaxis
over six months ago at zacks.com         
Heres What Key Metrics Tell Us About Deciphera Pharmaceuticals Q1 Earnings
zacks News
over six months ago at news.google.com         
Deciphera Pharmaceuticals Investment Analysts Weekly Ratings Changes - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Biotech Stock Roundup GILDs GSK Q1 Earnings, DCPH Soars on Acquisition News More
Yahoo News
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates HRT, DCPH, UMBF
benzinga news
over six months ago at seekingalpha.com         
ONO to acquire Deciphera Pharmaceuticals in 2.4B deal
seekingalpha News
over six months ago at businesswire.com         
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For 2.4 Billion
businesswire News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at zacks.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
zacks News
few days ago at thelincolnianonline.com         
Toronto Dominion Bank Sells 22,878 Shares of Biogen Inc.
news
few days ago at thelincolnianonline.com         
Biogen Hits New 12-Month Low Should You Sell?
news
few days ago at businesswire.com         
n-Lorem Foundations Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for...
businesswire News
few days ago at seekingalpha.com         
Biogen ALS drug needs to be covered by MA plans, CMS says
seekingalpha News
over a week ago at thelincolnianonline.com         
Biogen Inc. Shares Sold by Insigneo Advisory Services LLC
news
over a week ago at finance.yahoo.com         
Biogen Stock Declines 21.4 percent in 3 Months How to Play the Stock
Yahoo News
over a week ago at investing.com         
Jefferies downgrades Biogen stock, highlights Ocrevus royalty risk and pipeline gaps
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Biogen cut at Jefferies as 2025 has a tough setup
Yahoo News
2 days ago at gurufocus.com         
New InsiGHTS Trial of TransCon hGH in Turne
Gurufocus Stories at Macroaxis
few days ago at globenewswire.com         
FDA Accepts Ascendis Pharmas Supplemental Biologics License Application for TransCon hGH for the Tre...
Macroaxis News: globenewswire.com
few days ago at gurufocus.com         
Ascendis Pharma AS Announces FDA Review Acceptance for Adult Growth Hormone Deficiency ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Ascendis Pharma Selects PANTHERx Rare for the Distribution of YORVIPATH
Yahoo News
over two weeks ago at finance.yahoo.com         
Health Canada approves Novo Nordisks Wegovy to cut heart attacks
Yahoo News
over three weeks ago at news.google.com         
Ascendis Pharmas SWOT analysis stock faces growth hurdles amid pipeline promise - Investing.com Indi...
Google News at Macroaxis
over a month ago at simplywall.st         
Ascendis Pharma Third Quarter 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
Ascendis Pharma AS Receives Outperform Rating from Wedbush
news
over a month ago at investing.com         
TD Cowen cuts Ascendis Pharma target to 153, keeps buy rating
Investing News at Macroaxis
over a month ago at thelincolnianonline.com         
Sivik Global Healthcare LLC Buys Shares of 10,000 Ascendis Pharma AS
news
a day ago at benzinga.com         
Biohaven Advances in Immunotherapy Significant IgG Reduction Achieved with BHV-1300, Gains Analyst A...
benzinga news
over a week ago at investing.com         
Piper Sandler maintains stock target on argenx, cites growth potential
Investing News at Macroaxis
over a week ago at investing.com         
Immunovants SWOT analysis stock undervalued amid promising Graves disease treatment
Investing News at Macroaxis
over two weeks ago at thelincolnianonline.com         
HighVista Strategies LLC Has 3.88 Million Position in argenx SE
news
over three weeks ago at investing.com         
Jefferies reaffirms Buy rating on argenx stock, ups target amid promising trial updates
Investing News at Macroaxis
over three weeks ago at gurufocus.com         
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Gurufocus Stories at Macroaxis
over three weeks ago at insidermonkey.com         
Is argenx SE the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a month ago at gurufocus.com         
Deep Track Capital, LP Increases Stake in Vigil Neuroscience Inc
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Artisan Partners Limited Partnership Adjusts Stake in RxSight Inc
Gurufocus Stories at Macroaxis
over a month ago at investing.com         
argenx stock boosted by Wolfe, citing dominance in MG and profitability ahead
Investing News at Macroaxis
a minute ago at zacks.com         
Amgen Inc. Is a Trending Stock Facts to Know Before Betting on It
zacks News
2 days ago at investors.com         
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
Investors Business Daily at Macroaxis
3 days ago at businesswire.com         
Celltrion ontvangt positief CHMP-advies voor drie biosimilars in de Europese Unie
businesswire News
few days ago at finance.yahoo.com         
How Much Would It Take To Earn 100 A Month From Amgen Stock
Yahoo News
few days ago at finance.yahoo.com         
Amgen to build 1B North Carolina pharmaceutical plant
Yahoo News
few days ago at benzinga.com         
Drug Price Hikes Unsupported By Evidence Cost US 815 Million ICER Report
benzinga news
few days ago at finance.yahoo.com         
Why Amgen is a Top Growth Stock for the Long-Term
Yahoo News
few days ago at finance.yahoo.com         
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer
Yahoo News
six days ago at finance.yahoo.com         
Call for Application for 2025 Tsinghua Amgen Scholars Program
Yahoo News
over a week ago at kalkinemedia.com         
Digital Biomarkers Market CAGR of 34.1 percent size, share and major trends 2024-2031 AliveCor Inc.,...
news
a day ago at finance.yahoo.com         
Press Registration Is Now Open for the 2025 ACMG Annual Clinical Genetics Meeting
Yahoo News
3 days ago at investing.com         
BridgeBios SWOT analysis genetic disease specialists stock poised for growth
Investing News at Macroaxis
six days ago at finance.yahoo.com         
Are BioMarin Pharmaceutical Inc.s Mixed Financials The Reason For Its Gloomy Performance on The Stoc...
Yahoo News
over a week ago at finance.yahoo.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
Yahoo News
over a week ago at finance.yahoo.com         
Are You a Growth Investor This 1 Stock Could Be the Perfect Pick
Yahoo News
over a week ago at simplywall.st         
BioMarin Pharmaceutical investors are sitting on a loss of 29 percent if they invested a year ago
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Disposition of 372 shares by Erin Burkhart of Biomarin Pharmaceutical at 83.87 subject to Rule 16b-3
Yahoo News
over two weeks ago at thelincolnianonline.com         
Freedom Investment Management Inc. Reduces Stock Position in BioMarin Pharmaceutical Inc.
news
over two weeks ago at www.macroaxis.com         
Disposition of 14295 shares by Alexander Hardy of Biomarin Pharmaceutical at 66.03 subject to Rule 1...
Macroaxis News
over two weeks ago at finance.yahoo.com         
Why Is BioMarin Down 1.9 percent Since Last Earnings Report?
Yahoo News
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
2 days ago at statnews.com         
Viridian confirms benefit of drug for thyroid eye disease
news
few days ago at seekingalpha.com         
Neurocrine stock on watch after FDA nod
seekingalpha News
few days ago at investing.com         
Neurocrine Biosciences SWOT analysis stock faces mixed pipeline results, regulatory challenges
Investing News at Macroaxis
over a week ago at thelincolnianonline.com         
Y Intercept Hong Kong Ltd Makes New Investment in Neurocrine Biosciences, Inc.
news
over two weeks ago at investing.com         
Neurocrine Biosciences chief scientific officer sells 294k in stock
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Why Neurocrine Biosciences Is the Most Profitable Pharmaceutical Stock Right Now?
Yahoo News
over two weeks ago at thelincolnianonline.com         
Qsemble Capital Management LP Buys Shares of 10,743 Neurocrine Biosciences, Inc.
news
over three weeks ago at thelincolnianonline.com         
Eagle Asset Management Inc. Cuts Stake in Neurocrine Biosciences, Inc.
news
over three weeks ago at businesswire.com         
Helpr Employer-Subsidized Family Care App with Patented My Choice Technology Expands Service to 150 ...
businesswire News
over a year ago at news.google.com         
Netupitant Palonosetron FDC Market Size is Expected to Exhibit US 532228.43 million by 2028 Eisai Ph...
Google News at Macroaxis
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
2 days ago at ndtv.com         
Brazil Heron Flies After Rescuers Remove Plastic Cup From Its Throat
news
over two weeks ago at aol.com         
School pilot scheme to assess neurodivergent needs
news
over three weeks ago at bbc.co.uk         
Heron Foods Grimsby store must have security to sell alcohol
news
over a month ago at thelincolnianonline.com         
Heron Therapeutics Posts Earnings Results, Meets Expectations
news
over a month ago at gurufocus.com         
Heron Therapeutics Inc Q3 2024 Earnings Call Highlights Strategic Initiatives Drive ...
Gurufocus Stories at Macroaxis
over a month ago at insidermonkey.com         
Heron Therapeutics, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a month ago at zacks.com         
Heron Therapeutics Q3 Earnings How Key Metrics Compare to Wall Street Estimates
zacks News
over a month ago at seekingalpha.com         
Heron Therapeutics Q3 2024 Earnings Preview
seekingalpha News
over a month ago at thelincolnianonline.com         
Heron Therapeutics Set to Announce Earnings on Tuesday
news
over a month ago at finance.yahoo.com         
Journey Medical Soars 7.3 percent Is Further Upside Left in the Stock?
Yahoo News
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets